Next event: Indicative plenary sitting date, 1st reading/single reading 2021/07/05 more...
- Reasoned opinion 2021/03/25
- Committee draft report 2021/03/23
- Committee referral announced in Parliament, 1st reading/single reading 2020/12/14
- MÉLIN Joëlle (ID) appointed as rapporteur in ITRE 2020/12/03
- GONZÁLEZ CASARES Nicolás (S&D) appointed as rapporteur in ENVI 2020/11/25
Progress: Awaiting committee decision
Role | Committee | Rapporteur | Shadows |
---|---|---|---|
Lead | ENVI | GONZÁLEZ CASARES Nicolás ( S&D) | BUŞOI Cristian-Silviu ( EPP), RIES Frédérique ( Renew), METZ Tilly ( Verts/ALE), MÉLIN Joëlle ( ID), KOPCIŃSKA Joanna ( ECR), KONEČNÁ Kateřina ( GUE/NGL) |
Committee Opinion | IMCO | ||
Committee Opinion | ITRE | MÉLIN Joëlle ( ID) | Aldo PATRICIELLO ( PPE), Marc BOTENGA ( GUE/NGL), Jutta PAULUS ( Verts/ALE), Ivo HRISTOV ( S&D), Ivars IJABS ( RE), Margarita DE LA PISA CARRIÓN ( ECR) |
Committee Opinion | BUDG |
Lead committee dossier:
Legal Basis:
TFEU 114-p1, TFEU 168-p4
Legal Basis:
TFEU 114-p1, TFEU 168-p4Subjects
Events
PURPOSE: to reinforce the role of the European Medicines Agency (EMA) in crisis preparedness and management for medicinal products and medical devices.
PROPOSED ACT: Regulation of the European Parliament and of the Council.
ROLE OF THE EUROPEAN PARLIAMENT: the European Parliament decides in accordance with the ordinary legislative procedure and on an equal footing with the Council.
BACKGROUND: the unprecedented experience of the COVID-19 pandemic has demonstrated that the EU’s ability to coordinate work to ensure the availability of medicinal products and medical devices and facilitate their development is currently limited.
The COVID-19 pandemic has exacerbated the problem of shortages for certain medicinal products considered as critical in addressing the pandemic, and has highlighted the structural limitations in the EU’s ability to rapidly and effectively react to such challenges during public health crises.
The proposal is part of a package of closely associated measures that aim to reinforce the crisis preparedness and response and enhance the role of the European Centre for Disease Prevention and Control (ECDC). Together, they form part of the EU’s overall health response to COVID-19 as well as an improved crisis management framework.
CONTENT: the proposed Regulation should develop the core tasks already given to the EMA to ensure the quality, safety and efficacy of medicinal products with the potential to address public health emergencies.
It would complement the measures directed at improving the overall EU crisis management framework by addressing the specific issues related to medicinal product and medical device sectors and the tasks of the Agency. It would thus introduce new rules for the Agency with the objective to provide mechanisms within the Agency to:
monitor and mitigate the risk of shortages of critical medicines and medical devices; provide scientific advice on medicines which may have the potential to treat, prevent or diagnose the diseases causing those crises; coordinate studies to monitor the effectiveness and safety of vaccines; coordinate clinical trials.
Budgetary implications
The financial impact of this proposal on the EU budget should be part of the next Multiannual Financial Framework 2021-2027. The budgetary implications should relate mainly to administrative, scientific and IT support.
Documents
- Reasoned opinion: PE691.143
- Committee draft report: PE680.818
- Legislative proposal published: COM(2020)0725
- Legislative proposal published: EUR-Lex
- Committee draft report: PE680.818
- Reasoned opinion: PE691.143
Activities
- Cristian-Silviu BUŞOI
Plenary Speeches (0)
- Dita CHARANZOVÁ
Plenary Speeches (0)
- Jytte GUTELAND
Plenary Speeches (0)
- Kateřina KONEČNÁ
Plenary Speeches (0)
- Peter LIESE
Plenary Speeches (0)
- Tilly METZ
Plenary Speeches (0)
- Roberta METSOLA
Plenary Speeches (0)
- Alessandra MORETTI
Plenary Speeches (0)
- Frédérique RIES
Plenary Speeches (0)
- Waldemar TOMASZEWSKI
Plenary Speeches (0)
- Nicolás GONZÁLEZ CASARES
Plenary Speeches (0)
- Mislav KOLAKUŠIĆ
Plenary Speeches (0)
- Lefteris NIKOLAOU-ALAVANOS
Plenary Speeches (0)
- Jutta PAULUS
Plenary Speeches (0)
- Ivan Vilibor SINČIĆ
Plenary Speeches (0)
- Bartosz ARŁUKOWICZ
Plenary Speeches (0)
- Nathalie COLIN-OESTERLÉ
Plenary Speeches (0)
- Joanna KOPCIŃSKA
Plenary Speeches (0)
- Lídia PEREIRA
Plenary Speeches (0)
- Edina TÓTH
Plenary Speeches (0)
- Sara CERDAS
Plenary Speeches (0)
- Heléne FRITZON
Plenary Speeches (0)
- Ivo HRISTOV
Plenary Speeches (0)
- Silvia SARDONE
Plenary Speeches (0)
- Véronique TRILLET-LENOIR
Plenary Speeches (0)
- Ivan DAVID
Plenary Speeches (0)
- Mikuláš PEKSA
Plenary Speeches (0)
- Margarita DE LA PISA CARRIÓN
Plenary Speeches (0)
- Romana JERKOVIĆ
Plenary Speeches (0)
History
(these mark the time of scraping, not the official date of the change)
committees/0 |
|
committees/0 |
|
docs/0 |
|
docs/0 |
|
docs/1 |
|
committees/0 |
|
committees/0 |
|
committees/0 |
|
committees/0 |
|
committees/2 |
|
committees/2 |
|
forecasts |
|
committees/0 |
|
committees/0 |
|
committees/2 |
|
committees/2 |
|
committees/0 |
|
committees/0 |
|
committees/2 |
|
committees/2 |
|
committees/0 |
|
committees/0 |
|
committees/2 |
|
committees/2 |
|
events/1 |
|
procedure/Legislative priorities |
|
procedure/dossier_of_the_committee |
|
procedure/stage_reached |
Old
Preparatory phase in ParliamentNew
Awaiting committee decision |
commission |
|
committees/1/opinion |
False
|
committees/2/rapporteur |
|
committees/3/opinion |
False
|
events/0/summary |
|
committees/0/rapporteur |
|
otherinst |
|
procedure/other_consulted_institutions |
European Economic and Social Committee European Committee of the Regions
|